Archive

Rebel Category: REBEL EM

Data from Israel on the BNT162b2 (Pfizer) mRNA COVID-19 Vaccine

Background: COVID-19 vaccination is ramping up both in the US as well as throughout the world. Randomized clinical trials looking at the efficacy of the mRNA vaccines demonstrated 94% to 95% reductions in symptomatic cases (Polack 2020). Randomized clinical trials ...

Read More
Infectious Disease

Systemic Review and Meta Analysis on Topical Pain Control in Corneal Abrasions

 Background Information: Corneal abrasions are responsible for the largest proportion of eye-related chief complaints in patients presenting to emergency departments in the United States. There is substantial variability in physician practice when it comes to pain control. Ophthalmology literature has ...

Read More
Head, Eye, Ear, Nose, and Throat

Data from Israel in Health-Care Workers Vaccinated with 1st Dose of the Pfizer COVID-19 Vaccine

Background: Israel has succeeded in ramping up its vaccination program faster than any nation in the world. In December 2020, Israel began a national immunization campaign prioritizing health-care workers. In the original clinical trial data, the Pfizer vaccine was estimated ...

Read More
Infectious Disease

Characteristics of EM Malpractice Claims

Background: While we try not to think about it, the spectre of litigation hovers around the house of medicine. Medical malpractice books have been written, physicians have found their niche discussing and writing about it and blogs have been started ...

Read More

The HEAR Score: Does Very Low-Risk Acute Chest Pain Not Require Troponin Testing?

Background:  Chest pain is one of the most frequent presenting patient complaints in emergency departments (ED) and has an extensive differential diagnosis with very different levels of severity (1). Many of these chest pain presentations require a significant stay in ...

Read More
Cardiovascular
Showing Slide 1 of 6
rebelSWAG-lightbg
gsep-logo-1

Sponsored